跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NINLARO CAPSULE 2.3mg - HSA Drug Approval Details
Approvals
/
HSA
/
NINLARO CAPSULE 2.3mg
Approved
STANDARD
NINLARO CAPSULE 2.3mg
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
a42f8b07e3655540
Company
Unknown
Type
Standard
Approval Details
Approval Id
a42f8b07e3655540
Drug Name
NINLARO CAPSULE 2.3mg
Active Ingredients
Ixazomib citrate 3.3mg eqv ixazomib
2.3mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
a42f8b07e3655540
Type
Standard
Back to HSA Approvals